压力超负荷驱动心力衰竭小鼠心脏免疫浸润的单细胞测序揭示免疫激活范围
研究采用单细胞RNA测序绘制小鼠非缺血性压力超负荷心力衰竭模型心脏CD45+免疫细胞图谱,覆盖疾病早期、晚期及对照。发现健康与患病心脏均存在主要免疫细胞亚群,压力超负荷诱导几乎所有免疫细胞类型激活,并上调促炎巨噬细胞oncostatin M和调节性T细胞PD-1等亚群特异性分子,可能解释心衰对抗TNF治疗抵抗及抗PD-1免疫治疗心脏毒性。
要点
- 压力超负荷心衰中免疫激活涉及中性粒细胞、B细胞、NK细胞和肥大细胞等远超既往认知的细胞类型。
- 促炎巨噬细胞oncostatin M上调可能解释心衰对抗TNF治疗抵抗。
- 调节性T细胞PD-1上调可能与抗PD-1免疫治疗心脏毒性相关。
核心结论
- 即使无感染或自身免疫触发,压力超负荷诱导的疾病仍导致涉及中性粒细胞、B细胞、NK细胞和肥大细胞等更多细胞类型的免疫激活。
- 亚群特异性激活分子可能成为心力衰竭诊断或治疗的有用靶点。
研究设计与样本
- 采用单细胞RNA测序分析标准小鼠非缺血性压力超负荷心力衰竭模型心脏CD45+细胞,比较疾病早期、晚期与对照。
- 整合多参数流式细胞术、免疫组化和组织透明化免疫荧光在小鼠和人中验证。
主要发现
- 大多数主要免疫细胞亚群包括巨噬细胞、B细胞、T细胞、调节性T细胞、树突状细胞、NK细胞、中性粒细胞和肥大细胞在健康和患病心脏中均存在。
- 大多数细胞亚群位于心肌内,而肥大细胞也见于心外膜。
- 压力超负荷诱导后,整个免疫细胞类型范围均发生免疫激活。
- 激活导致亚群特异性分子上调,如促炎巨噬细胞的oncostatin M和调节性T细胞的PD-1。
临床怎么用
- 应关注中性粒细胞、B细胞、NK细胞和肥大细胞等此前较少研究的免疫亚群在心衰中的作用。
- 可借鉴已开发的免疫亚群研究工具包推进心脏免疫学探索。
- 亚群特异性分子有望成为心力衰竭诊断或治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inflammation is a key component of cardiac disease, with macrophages and T lymphocytes mediating essential roles in the progression to heart failure. Nonetheless, little insight exists on other immune subsets involved in the cardiotoxic response. METHODS: Here, we used single-cell RNA sequencing to map the cardiac immune composition in the standard murine nonischemic, pressure-overload heart failure model. By focusing our analysis on CD45+ cells, we obtained a higher resolution identification of the immune cell subsets in the heart, at early and late stages of disease and in controls. We then integrated our findings using multiparameter flow cytometry, immunohistochemistry, and tissue clarification immunofluorescence in mouse and human. RESULTS: We found that most major immune cell subpopulations, including macrophages, B cells, T cells and regulatory T cells, dendritic cells, Natural Killer cells, neutrophils, and mast cells are present in both healthy and diseased hearts. Most cell subsets are found within the myocardium, whereas mast cells are found also in the epicardium. Upon induction of pressure overload, immune activation occurs across the entire range of immune cell types. Activation led to upregulation of key subset-specific molecules, such as oncostatin M in proinflammatory macrophages and PD-1 in regulatory T cells, that may help explain clinical findings such as the refractivity of patients with heart failure to anti-tumor necrosis factor therapy and cardiac toxicity during anti-PD-1 cancer immunotherapy, respectively. CONCLUSIONS: Despite the absence of infectious agents or an autoimmune trigger, induction of disease leads to immune activation that involves far more cell types than previously thought, including neutrophils, B cells, Natural Killer cells, and mast cells. This opens up the field of cardioimmunology to further investigation by using toolkits that have already been developed to study the aforementioned immune subsets. The subset-specific molecules that mediate their activation may thus become useful targets for the diagnostics or therapy of heart failure.
引用
- Martini E, Kunderfranco P, Peano C, et al. Single-Cell Sequencing of Mouse Heart Immune Infiltrate in Pressure Overload-Driven Heart Failure Reveals Extent of Immune Activation. Circulation. 2019. PMID: 31661975. doi:10.1161/CIRCULATIONAHA.119.041694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。